NCT01129284 - Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Treatment Resistant Nephrotic Syndrome

Interventions

DRUG

ACTHAR gel

Patients will be treated with ACTHAR gel starting with 40 units given twice weekly subcutaneously for two weeks, then 80 units given twice weekly subcutaneously afterwards for a period of up to six months.

Trial Locations (1)

10032

Columbia University Medical Center, New York